Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Strauss

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cardiovascular and Interventional Radiology|May 15, 2013
Outcome after radiofrequency ablation of sarcoma lung metastasesClaus Koelblinger, Sandra Strauss, Alice Gillams
Expert Opinion on Investigational Drugs|February 25, 2009
Experimental therapies in Ewing's sarcomaRachael Windsor, Sandra Strauss, Beatrice Seddon, et al.
British Journal of Haematology|October 1, 2010
Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemiaAgathoclis Agathocleous, Ama Rohatiner, Simon Rule, et al.
British Journal of Cancer|July 29, 2025
Prognostic factors in patients with relapsed high-grade osteosarcoma: a systematic reviewAlba Rubio-San-Simón, William Wilson, Giovanna Sironi, et al.
Lancet (London, England)|December 15, 2022
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trialBernadette Brennan, Laura Kirton, Perrine Marec-Bérard, et al.
JCO Precision Oncology|September 19, 2025
Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing ConsortiumAntonio Juan Ribelles, Arthur Felix, Nuria Benavent, et al.
Clinical Sarcoma Research|May 12, 2020
Real-world experience with doxorubicin and olaratumab in soft tissue sarcomas in England and Northern IrelandSpyridon Gennatas, Florence Chamberlain, Thomas Carter, et al.
Trials|January 19, 2020
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 ProtocolJennifer Anderton, Veronica Moroz, Perrine Marec-Bérard, et al.
Cell Death and Differentiation|September 22, 2022
Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of boneLucia Cottone, Lorena Ligammari, Hang-Mao Lee, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2024
Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trialsXavier Choderlos de Laclos, Séverine Risbourg, Bernadette Brennan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cardiovascular and Interventional Radiology|May 15, 2013
Outcome after radiofrequency ablation of sarcoma lung metastasesClaus Koelblinger, Sandra Strauss, Alice Gillams
Expert Opinion on Investigational Drugs|February 25, 2009
Experimental therapies in Ewing's sarcomaRachael Windsor, Sandra Strauss, Beatrice Seddon, et al.
British Journal of Haematology|October 1, 2010
Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemiaAgathoclis Agathocleous, Ama Rohatiner, Simon Rule, et al.
British Journal of Cancer|July 29, 2025
Prognostic factors in patients with relapsed high-grade osteosarcoma: a systematic reviewAlba Rubio-San-Simón, William Wilson, Giovanna Sironi, et al.
Lancet (London, England)|December 15, 2022
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trialBernadette Brennan, Laura Kirton, Perrine Marec-Bérard, et al.
JCO Precision Oncology|September 19, 2025
Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing ConsortiumAntonio Juan Ribelles, Arthur Felix, Nuria Benavent, et al.
Clinical Sarcoma Research|May 12, 2020
Real-world experience with doxorubicin and olaratumab in soft tissue sarcomas in England and Northern IrelandSpyridon Gennatas, Florence Chamberlain, Thomas Carter, et al.
Trials|January 19, 2020
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 ProtocolJennifer Anderton, Veronica Moroz, Perrine Marec-Bérard, et al.
Cell Death and Differentiation|September 22, 2022
Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of boneLucia Cottone, Lorena Ligammari, Hang-Mao Lee, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2024
Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trialsXavier Choderlos de Laclos, Séverine Risbourg, Bernadette Brennan, et al.
Pageof 2